Veerhealth Care Ltd Issues Corrigendum and Submits Newspaper Publication for Postal Ballot

3 min read     Updated on 16 Apr 2026, 05:21 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Veerhealth Care Limited has issued a corrigendum to its postal ballot notice dated March 31, 2026, for the issuance of up to 1,00,00,000 fully convertible warrants worth Rs. 20,25,00,000. The company submitted newspaper publication compliance to BSE on April 16, 2026, with the corrigendum published in English and Marathi newspapers. Key modifications include additional disclosure of Yogesh Shah HUF's participation with 9,00,000 warrants and corrected shareholding patterns for existing promoters.

powered bylight_fuzz_icon
37803444

*this image is generated using AI for illustrative purposes only.

Veerhealth Care Ltd has issued a corrigendum to its postal ballot notice dated March 31, 2026, incorporating necessary modifications and additional disclosures for the proposed issuance of fully convertible warrants. The company filed the corrigendum with BSE Limited on April 15, 2026, and subsequently submitted newspaper publication details on April 16, 2026.

Newspaper Publication Compliance

Veerhealth Care Limited submitted the newspaper publication of its postal ballot notice corrigendum to BSE Limited on April 16, 2026. The extract of the corrigendum was published in compliance with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Publication Details: Information
English Newspaper: Newshub Newspaper
Marathi Newspaper: Pratakhkal Newspaper
Publication Date: April 16, 2026
Submitted By: Bhavin Satish Shah, Managing Director

Key Modifications in the Corrigendum

The corrigendum addresses several important aspects of the original postal ballot notice for the issuance of up to 1,00,00,000 fully convertible warrants:

Additional Promoter Participation

The company added disclosure regarding Yogesh Shah HUF's participation in the warrant issuance:

Entity: Category Type of Security Number of Securities
Yogesh Shah HUF: Promoter Warrants 9,00,000

Shareholding Pattern Corrections

The corrigendum corrected the shareholding pattern table, specifically addressing inadvertent highlighting in the original notice. Additionally, it provided updated post-issue shareholding details for Panna Pankaj Bhai Shah:

Parameter: Pre-issue Post-issue (Full Conversion)
Number of Shares: 11,000 14,12,000
Percentage Holding: 0.06% 4.71%
Warrants to be Allotted: - 14,01,000

Warrant Issuance Details

The postal ballot seeks shareholder approval for issuing up to 1,00,00,000 fully convertible warrants aggregating Rs. 20,25,00,000 at an issue price of Rs. 20.25 per warrant. The warrants will be issued to both promoter and non-promoter categories on a preferential basis.

Proposed Allottee Categories

Category: Amount (Rs.)
Promoter & Promoter Group: 10,18,74,250.00
Non-Promoter: 10,06,25,750.00
Total: 20,25,00,000.00

Key Terms and Conditions

The warrants carry the following key features:

Feature: Details
Conversion Period: 18 months from allotment date
Initial Payment: 25% of warrant price at allotment
Balance Payment: 75% at conversion time
Lock-in Period: As per SEBI ICDR Regulations
Conversion Ratio: One equity share per warrant

Utilization of Proceeds

The company plans to utilize the issue proceeds for expansion and general corporate purposes:

Purpose: Amount (Rs.) Timeline
Plant and Machinery: 9,74,00,000.00 By October 31, 2027
Electrical and Electronics: 2,03,00,000.00 By October 31, 2027
Furniture & Fixtures: 1,31,00,000.00 By October 31, 2027
Office Equipment: 2,12,00,000.00 By October 31, 2027
General Corporate Purpose: 5,05,00,000.00 By October 31, 2027

E-Voting Process

The e-voting facility is provided through NSDL, with the following schedule:

Parameter: Details
Commencement: April 1, 2026, at 9:00 AM IST
Conclusion: April 30, 2026, at 5:00 PM IST
Cut-off Date: March 27, 2026
Scrutinizer: M/s. Nidhi Shah & Associates

The corrigendum clarifies that all other terms and conditions of the original postal ballot notice remain unchanged, except for the modifications specified. The document emphasizes that these corrections do not result in any change in management control of the company.

Historical Stock Returns for Veerhealth Care

1 Day5 Days1 Month6 Months1 Year5 Years
+0.70%+4.60%+0.10%+12.50%+35.27%+113.16%

How will the significant dilution from converting 1 crore warrants impact Veerhealth Care's earnings per share and market valuation?

What specific healthcare equipment or technology will the company acquire with the Rs. 15+ crores allocated for plant, machinery, and electronics?

Will the substantial increase in Panna Pankaj Bhai Shah's shareholding from 0.06% to 4.71% signal any changes in the company's strategic direction?

Veerhealth Care Limited Secures $1,60,650 Order from New York-Based Company for Personal Care Products

1 min read     Updated on 11 Apr 2026, 01:12 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Veerhealth Care Limited has secured a $1,60,650 order from a New York-based company for personal care products, valued at approximately ₹150 lakhs. The international contract involves supplying body care products within 45 days on FOB NHava Seva terms. The company expects this order to contribute to additional turnover growth, demonstrating its expanding global market presence.

powered bylight_fuzz_icon
37438955

*this image is generated using AI for illustrative purposes only.

Veerhealth care Limited has announced securing a substantial international order worth $1,60,650 (approximately ₹150 lakhs) from a New York-based company for personal care products. The announcement was made on April 11, 2026, through a regulatory filing under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Order Details and Financial Impact

The order represents a significant business opportunity for the company, with management anticipating additional growth in turnover from this international engagement. The contract involves the supply of body care products to be executed within a 45-day timeframe.

Parameter: Details
Order Value: $1,60,650 (₹150 lakhs)
Client Location: New York, USA
Product Type: Body care products
Execution Period: 45 days
Terms: FOB NHava Seva

Regulatory Compliance and Disclosure

The company has provided comprehensive details as required under SEBI regulations, ensuring full transparency regarding the transaction. Key regulatory aspects include:

  • Client Identity: Not disclosed due to confidential terms
  • Transaction Nature: International supply contract
  • Related Party Status: No related party involvement
  • Promoter Interest: No promoter or group company interest in the awarding entity

Business Significance

This international order demonstrates Veerhealth Care's expanding presence in global markets, particularly in the personal care segment. The contract's execution within 45 days indicates the company's operational readiness to fulfill international demands efficiently.

The order falls under the company's body care products portfolio, highlighting the market acceptance of their ayuVeer brand in international markets. With manufacturing facilities located at Vapi, Gujarat, the company is well-positioned to execute this order within the specified timeframe.

Company Operations

Veerhealth Care Limited operates with its registered office in Mumbai and manufacturing works at Plot No. 224, Vibrant Business Park, Vapi, Gujarat. The company's dual-brand strategy includes both Veerhealth Care and ayuVeer product lines, catering to domestic and international markets.

Historical Stock Returns for Veerhealth Care

1 Day5 Days1 Month6 Months1 Year5 Years
+0.70%+4.60%+0.10%+12.50%+35.27%+113.16%

Will this New York partnership lead to additional orders or a long-term supply agreement for Veerhealth Care's body care products?

How might this international success impact Veerhealth Care's expansion strategy into other major markets like Europe or Asia-Pacific?

Could this $160,650 order serve as a catalyst for scaling up manufacturing capacity at the Vapi facility to meet growing international demand?

More News on Veerhealth Care

1 Year Returns:+35.27%